Earth Science Tech, Inc. (OTC: ETST) announced the results of its first Annual Meeting of Stockholders, held virtually on Aug. 31, 2026. During the meeting, shareholders voted in favor of key proposals that could significantly alter the company's future trajectory, including a strategy to pursue an uplisting to a national securities exchange and the retirement of its Series B Preferred Stock.
According to the company, shareholders approved a reverse stock split, which will remain valid for 12 months. The board of directors may implement the split only if it deems it necessary to meet the minimum bid-price requirements for uplisting to a national exchange, such as the Nasdaq or NYSE. This move is part of a broader effort to enhance the company's visibility and liquidity in the capital markets.
In addition, shareholders authorized the board's independent Special Committee to negotiate the retirement of the Series B Preferred Stock. The company stated that this step would eliminate its dual-class, super-voting control structure, potentially making the company more attractive to institutional investors and aligning its governance with best practices.
Other items approved during the meeting included a cash-only “Say-on-Pay” executive compensation structure, with a three-year review cycle. All seven director nominees were re-elected, and Semple, Marchal & Cooper, LLP was ratified as the independent registered public accounting firm for the company.
The company also noted that an audio replay of the meeting is available, which includes management guidance, additional details on the approved proposals, and a shareholder question-and-answer session. For more information, the full press release can be accessed at https://ibn.fm/KCU5p.
Earth Science Tech operates as a diversified holding company focused on the health and wellness sector. Its principal operating strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company's healthcare operations are supported by investments in real estate and asset management activities, as well as a consumer products business.
The core of the company's value proposition lies in the seamless integration of patient care, from consultation to fulfillment, achieved through the synergy of its specialized subsidiaries. This announcement marks a significant step for Earth Science Tech as it seeks to strengthen its position in the market and potentially access a broader range of investors through an uplisting.
